
DARE
Healthcare · Biotechnology · $12.9M market cap
$0.6574+0.01 (+2.0%)Nov 13, 4:00 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +20.8% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 16, 2026 · upcoming | After the close | -0.13 | — | — |
| Aug 13, 2026 | After the close | -0.33 | -0.20 | +39.4% |
| May 14, 2026 | After the close | -0.30 | -0.20 | +33.3% |
| Mar 27, 2026 | Time not confirmed | -0.42 | -0.10 | +76.0% |
| Nov 13, 2025 | After the close | -0.40 | -0.28 | +30.0% |
| Aug 14, 2025 | After the close | -0.58 | -0.45 | +22.4% |
| May 13, 2025 | After the close | -0.58 | -0.50 | +13.8% |
| Mar 26, 2025 | Before the open | -0.63 | -0.65 | -2.6% |
| Nov 14, 2024 | After the close | -0.71 | -0.55 | +22.5% |
| Aug 12, 2024 | After the close | -0.66 | -0.89 | -34.8% |
| May 14, 2024 | Before the open | -0.72 | -0.84 | -16.7% |
| Mar 28, 2024 | Before the open | -0.10 | -0.06 | +40.0% |
| Nov 9, 2023 | After the close | -1.20 |
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for…
| -1.08 |
| +10.0% |
| Aug 10, 2023 | Before the open | -1.08 | -1.20 | -11.1% |
| May 11, 2023 | Before the open | -1.20 | -1.08 | +10.0% |
| Mar 30, 2023 | Before the open | -0.14 | -0.19 | -35.7% |
| Nov 10, 2022 | Before the open | -1.36 | -0.96 | +29.4% |
| Aug 9, 2022 | Before the open | -0.76 | 0.06 | +107.9% |
| May 12, 2022 | Before the open | -0.14 | -0.10 | +28.6% |
| Mar 31, 2022 | Before the open | -2.16 | -2.16 | 0.0% |
| Nov 10, 2021 | Before the open | -2.10 | -2.16 | -2.9% |
| Aug 12, 2021 | Before the open | -1.96 | -2.16 | -10.2% |
| May 13, 2021 | Before the open | -2.96 | -2.07 | +30.1% |
| Mar 30, 2021 | Before the open | -0.13 | -0.28 | -115.4% |
| Nov 12, 2020 | Before the open | -2.22 | -2.88 | -29.7% |
| Aug 12, 2020 | Before the open | -2.04 | -3.24 | -58.8% |
| May 14, 2020 | Before the open | -3.92 | -2.16 | +44.9% |
| Mar 27, 2020 | After the close | -0.18 | -0.21 | -16.7% |
| Nov 12, 2019 | Before the open | -2.48 | -2.40 | +3.2% |
| Aug 14, 2019 | After the close | -2.34 | -3.48 | -48.7% |
| May 14, 2019 | After the close | -3.96 | -3.24 | +18.2% |
| Mar 31, 2019 | After the close | -0.27 | -0.25 | +7.4% |
| Nov 13, 2018 | Before the open | -2.96 | -2.76 | +6.8% |
| Aug 13, 2018 | After the close | -2.82 | -3.84 | -36.2% |
| May 14, 2018 | After the close | -0.88 | -0.88 | 0.0% |
| Mar 28, 2018 | After the close | -3.10 | -1.48 | +52.3% |